Zipeprol

Zipeprol
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Oral
ATC code
Legal status
Legal status
Identifiers
  • 1-methoxy- 3-[4-(2-methoxy- 2-phenylethyl)piperazin- 1-yl]- 1-phenylpropan- 2-ol
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
ECHA InfoCard100.047.432 Edit this at Wikidata
Chemical and physical data
FormulaC23H32N2O3
Molar mass384.520 g·mol−1
3D model (JSmol)
  • OC(CN1CCN(CC1)CC(OC)c2ccccc2)C(OC)c3ccccc3
  • InChI=1S/C23H32N2O3/c1-27-22(19-9-5-3-6-10-19)18-25-15-13-24(14-16-25)17-21(26)23(28-2)20-11-7-4-8-12-20/h3-12,21-23,26H,13-18H2,1-2H3 checkY
  • Key:VSTNNAYSCJQCQI-UHFFFAOYSA-N checkY
 X markNcheckY (what is this?)  (verify)

Zipeprol is a centrally acting cough suppressant developed in France in the 1970s. It is not a morphinan derivative (in contrast to both codeine and dextromethorphan). Zipeprol acts as a local anaesthetic and has mucolytic, antihistamine and anticholinergic properties. It is sold with several brand names such as Zinolta and Respilene. It is not available in the United States or Canada and has been discontinued in Europe. It is still available in some countries in Asia and South America.

Zipeprol has been misused in Korea as a deliriant. Such use is quite dangerous due to the risk of seizures and neurological damage at high dosages.